Healthcare provider profile · identity verified

Anne Eileen Tofte, MD

Family Practice · GRAND RAPIDS, MN · NPI 1073591160

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	276	75
Levothyroxine Sodium	Levothyroxine Sodium	192	44
Lisinopril	Lisinopril	184	44
Losartan Potassium	Losartan Potassium	183	41
Amlodipine Besylate	Amlodipine Besylate	153	41
Omeprazole	Omeprazole	141	41
Citalopram Hbr	Citalopram Hydrobromide	115	33
Sertraline Hcl	Sertraline Hcl	105	15
Pantoprazole Sodium	Pantoprazole Sodium	103	14
Rosuvastatin Calcium	Rosuvastatin Calcium	90	24
Simvastatin	Simvastatin	85	24
Metoprolol Succinate	Metoprolol Succinate	80	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Trazodone Hcl	Trazodone Hcl	57	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	54	13
Famotidine	Famotidine	53	suppressed
Metformin Hcl	Metformin Hcl	53	13
Gabapentin	Gabapentin	52	13
Divalproex Sodium	Divalproex Sodium	51	suppressed
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Donepezil Hcl	Donepezil Hcl	49	suppressed
Metformin Hcl Er	Metformin Hcl	46	11
Furosemide	Furosemide	44	17
Pravastatin Sodium	Pravastatin Sodium	44	13
Hydrochlorothiazide	Hydrochlorothiazide	43	15
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Pregabalin	Pregabalin	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	14
Jantoven	Warfarin Sodium	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Valacyclovir	Valacyclovir Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Baclofen	Baclofen	14	suppressed
Prednisone	Prednisone	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Ozempic	Semaglutide	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Eliquis	Apixaban	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error